Moasser MM - Search Results

1

HER family in cancer progression: From discovery to 2020 and beyond.

Kumar R, George B, Campbell MR, Verma N, Paul AM, Melo-Alvim C, Ribeiro L, Pillai MR, da Costa LM, Moasser MM. Kumar R, et al. Among authors: moasser mm. Adv Cancer Res. 2020;147:109-160. doi: 10.1016/bs.acr.2020.04.001. Epub 2020 Jun 5. Adv Cancer Res. 2020. PMID: 32593399 Review.

2

The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells.

Moasser MM, Basso A, Averbuch SD, Rosen N. Moasser MM, et al. Cancer Res. 2001 Oct 1;61(19):7184-8. Cancer Res. 2001. PMID: 11585753

3

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3.

Sergina NV, Rausch M, Wang D, Blair J, Hann B, Shokat KM, Moasser MM. Sergina NV, et al. Among authors: moasser mm. Nature. 2007 Jan 25;445(7126):437-41. doi: 10.1038/nature05474. Epub 2007 Jan 7. Nature. 2007. PMID: 17206155 Free PMC article.

4

Targeting HER proteins in cancer therapy and the role of the non-target HER3.

Hsieh AC, Moasser MM. Hsieh AC, et al. Among authors: moasser mm. Br J Cancer. 2007 Aug 20;97(4):453-7. doi: 10.1038/sj.bjc.6603910. Epub 2007 Jul 31. Br J Cancer. 2007. PMID: 17667926 Free PMC article. Review.

5

The HER family and cancer: emerging molecular mechanisms and therapeutic targets.

Sergina NV, Moasser MM. Sergina NV, et al. Among authors: moasser mm. Trends Mol Med. 2007 Dec;13(12):527-34. doi: 10.1016/j.molmed.2007.10.002. Epub 2007 Nov 5. Trends Mol Med. 2007. PMID: 17981505 Free PMC article. Review.

6

The epidermal growth factor receptor family: biology driving targeted therapeutics.

Wieduwilt MJ, Moasser MM. Wieduwilt MJ, et al. Among authors: moasser mm. Cell Mol Life Sci. 2008 May;65(10):1566-84. doi: 10.1007/s00018-008-7440-8. Cell Mol Life Sci. 2008. PMID: 18259690 Free PMC article. Review.

7

A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignancies.

Chien AJ, Illi JA, Ko AH, Korn WM, Fong L, Chen LM, Kashani-Sabet M, Ryan CJ, Rosenberg JE, Dubey S, Small EJ, Jahan TM, Hylton NM, Yeh BM, Huang Y, Koch KM, Moasser MM. Chien AJ, et al. Among authors: moasser mm. Clin Cancer Res. 2009 Sep 1;15(17):5569-75. doi: 10.1158/1078-0432.CCR-09-0522. Epub 2009 Aug 25. Clin Cancer Res. 2009. PMID: 19706807 Free PMC article. Clinical Trial.

8

HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy.

Campbell MR, Amin D, Moasser MM. Campbell MR, et al. Among authors: moasser mm. Clin Cancer Res. 2010 Mar 1;16(5):1373-83. doi: 10.1158/1078-0432.CCR-09-1218. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179223 Free PMC article.

9

The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics.

Amin DN, Campbell MR, Moasser MM. Amin DN, et al. Among authors: moasser mm. Semin Cell Dev Biol. 2010 Dec;21(9):944-50. doi: 10.1016/j.semcdb.2010.08.007. Epub 2010 Sep 9. Semin Cell Dev Biol. 2010. PMID: 20816829 Free PMC article. Review.

10

Trask loss enhances tumorigenic growth by liberating integrin signaling and growth factor receptor cross-talk in unanchored cells.

Spassov DS, Wong CH, Wong SY, Reiter JF, Moasser MM. Spassov DS, et al. Among authors: moasser mm. Cancer Res. 2013 Feb 1;73(3):1168-79. doi: 10.1158/0008-5472.CAN-12-2496. Epub 2012 Dec 12. Cancer Res. 2013. PMID: 23243018 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page